INL-001
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for INL-001, covering 2020-12-31 to 2023-02-13. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries [Phase 3]